Cargando…

Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360799/
http://dx.doi.org/10.1007/s40278-021-00463-8
_version_ 1783737818437124096
collection PubMed
description
format Online
Article
Text
id pubmed-8360799
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-83607992021-08-13 Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan Reactions Weekly Clinical Study Springer International Publishing 2021-08-14 2021 /pmc/articles/PMC8360799/ http://dx.doi.org/10.1007/s40278-021-00463-8 Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
title Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
title_full Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
title_fullStr Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
title_full_unstemmed Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
title_short Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
title_sort anaphylaxis after pfizer-biontech covid-19 vaccine in japan
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360799/
http://dx.doi.org/10.1007/s40278-021-00463-8